|
1
|
Hamilton JP and Meltzer SJ: A Review of
the Genomics of Gastric Cancer. Clin Gastroenterol Hepatol.
4:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu XD and Li J: Gastric carcinoma in
China: Current status and future perspectives (Review). Oncol Lett.
1:407–412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang CW, Zou SC, Shi D and Zhao DJ:
Clinical significance of preoperative regional intra-arterial
infusion chemotherapy for advanced gastric cancer. World J
Gastroenterol. 10:3070–3072. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li M, Zhang J, Wang D, Zhong B, Tucker S,
Lu S, Cheng J, Cao C, Xu J and Pan H: A phase II study of
intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and
mitomycin C for advanced nonresectable gastric cancer. Anticancer
Drugs. 20:941–945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shchepotin IB, Cborny V, Hanfelt J and
Evans SR: Palliative superselective intra-arterial chemotherapy for
advanced nonresectable gastric cancer. J Gastrointest Surg.
3:426–431. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 6:1471–4. 2010.
View Article : Google Scholar
|
|
8
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seldinger SI: Catheter replacement of the
needle in percutaneous arteriography; a new technique. Acta Radiol.
39:368–376. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miller AB, Hoogstraten B, Staguet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Cancer. 45:228–247.
2009.
|
|
12
|
Zhang C, Li G, Fan C, Xu J, Cao J, Liu S
and Li N: Comparison of efficacy of different route of
administration of chemotherapy on unresectable, advanced gastric
cancer. World J Surg Oncol. 10:1622012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakajima T, Ishihara S, Motohashi H,
Kitamura Y, Nakajima Y, Fujii M, Tokunaga A, Matai K, Anzai H and
Nishi M: Neo-Adjuvant chemotherapy for inoperable gastric cancer
via local and general delivery routes (FLEP Therapy)Cancer
Treatment An Update. Springer; Paris Germany: pp. 411–413. 1994,
View Article : Google Scholar
|
|
14
|
Shi DH, Cao JM, Gao DZ, Xu J, Kong WD, Li
CL and Wang ZQ: Modified FOLFOX regimen combined with
interventional therapy for the treatment of advanced gastric
cancer: A clinical study. Intervent Radiol. 18:759–762. 2009.
|
|
15
|
Zhu ZD and Pu YD: The study of
pharmacokinetics of 5-Fu after left gastric artery intra-arterial
infusion in treatment of gastric carcinoma. Chin J Bases Clin
General Surg. 8:26–28. 2001.
|
|
16
|
Tao HQ and Zou SC: Effect of preoperative
regional artery chemotherapy on proliferation and apoptosis of
gastric carcinoma cells. World J Gastroenterol. 8:451–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou SC and Tao HQ: Several questions
related on preoperative regional arterial chemotherapy for gastric
and colorectal cancer. World Chin J Digest. 15:477–481. 2007.
|
|
18
|
Gu X, Gao XS, Cui M, Xie M, Peng C, Bai Y,
Guo W, Han L, Gu X and Xiong W: Clinicopathological and prognostic
significance of platelet to lymphocyte ratio in patients with
gastric cancer. Oncotarget. 7:49878–49887. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho IR, Park JC, Park CH, Jo JH, Lee HJ,
Kim S, Shim CN, Lee H, Shin SK, Lee SK and Lee YC: Pre-treatment
neutrophil to lymphocyte ratio as a prognostic marker to predict
chemotherapeutic response and survival outcomes in metastatic
advanced gastric cancer. Gastric Cancer. 17:703–710. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamanaka T, Matsumoto S, Teramukai S,
Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of
neutrophils to lymphocytes is associated with patient prognosis in
advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim
KH and Kim HJ: Prognostic significance of neutmphil lymphocyte
ratio and platelet lymphocyte ratio in advanced gastric cancer
patients treated with FOLFOX chemotherapy. BMC Cancer. 13:3502013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang SC, Chou JF, Strong VE, Brennan MF,
Capanu M and Coit DG: Pre-treatment neutrophil to lymphocyte ratio
independently predicts disease specific survival in resectable GE
junction and gastric adenocarcinoma. Ann Surg. 263:292–297. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bald T, Quast T, Landsberg J, Rogava M,
Glodde N, Lopez-Ramos D, Kohlmeyer J, Riesenberg S, van den
Boorn-Konijnenberg D, Hömig-Hölzel C, et al:
Ultraviolet-radiation-induced inflammation promotes angiotropism
and metastasis in melanoma. Nature. 507:109–113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wada Y, Yoshida K, Tsutani Y, Shigematsu
H, Oeda M, Sanada Y, Suzuki T, Mizuiri H, Hamai Y, Tanabe K, et al:
Neutrophil elastase induces cell proliferation and migration by the
release of TGF-α, PDGF and VEGF in esophageal cell lines. Oncol
Rep. 17:161–167. 2007.PubMed/NCBI
|
|
25
|
Tian N and Zhang PT: Relationship between
neutrophilia and cancer progress or metastasis. Chin Canc.
19:470–476. 2010.
|
|
26
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smyth MJ, Dunn GP and Schreiber RD: Cancer
immunosurveillance and immunoediting: The roles of immunity in
suppressing tumor development and shaping tumor immunogenicity. Adv
Immunol. 90:1–50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ray-Coquard I, Cropet C, Van Glabbeke M,
Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P,
Labidi I, et al: Lymphopenia as a Prognostic Factor for Overall
Survival in Advanced Carcinomas, Sarcomas, and Lymphomas. Cancer
Res. 69:5383–5391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morris M, Platell C and Iacopetta B:
Tumor-infiltrating lymphocytes and perforation in colon cancer
predict positive response to 5-fluorouracil chemotherapy. Clin
Cancer Res. 14:1413–1417. 2008. View Article : Google Scholar : PubMed/NCBI
|
